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A B S T R A C T
Introduction: By 2030 cancer will kill one million Africans each year. Women will bear the heaviest burden, as
cancers of the breast and cervix are the most common malignancies and causes of cancer-related death in the
African region. National-level data that map the status of women’s cancer control services are needed to inform
strategies for implementing platforms for the early detection and treatment of these “priority” cancers.
Methods: Using mixed-methods, we assessed available services for breast and cervical cancer detection and
treatment at all provincial hospitals, the national referral hospital, and the national cancer treatment center in
Zambia.
Results: A system for cervical cancer prevention using visual inspection with acetic acid (VIA) and ablation/
excision of precancerous lesions has been established at the provincial level. The potential for mammography,
clinical breast examination, diagnostic ultrasound and biopsy exist at the provincial level, albeit on a much
smaller scale. Breast wedge resections and mastectomy can be performed in provinces where general surgeons
are located; however, breast conserving and reconstructive surgery are not available. Invasive cancers are
generally referred to University Teaching Hospital in Lusaka, where services for radiation, chemotherapy and
hormonal therapy are available but overburdened. Pathology services nationwide are woefully inadequate.
Discussion: The assessment revealed a critical need for centrally coordinated, but decentralized, public service
platforms for women’s cancer control. Efforts are underway, through multiple stakeholders, to implement re-
commendations related to training healthcare workers who can provide advanced diagnostic and therapeutic
services, improving pathology services, and innovative financing for these initiatives.
1. Introduction
The growing global cancer burden is increasingly falling on low-
and middle-income countries (LMICs), where nearly 80% of disability
adjusted life-years-lost to cancer occurs [1–4]. In Africa the need for
action is profound as it is predicted that by 2030 cancer will kill one
million Africans each year [2]. Women will bear the heaviest burden, as
cancers of the breast and cervix are the most common malignancies and
causes of cancer-related death in the African region.
2. Background
Breast cancer incidence rates in developing nations, although rising,
are much lower than those in developed nations. Mortality rates,
however, are just as high. System level barriers to breast cancer control
in LMICs are centered around the lack of screening, early detection,
diagnostic, and treatment facilities [5]. Although scarce, Zambia-spe-
cific data indicates that breast cancer incidence has been rising.
Cervical cancer is a major cause of cancer deaths among women in
LMICs. One in five cases reported globally occurs in sub-Saharan Africa
[6,7]. System level barriers are similar to those for breast cancer. HIV
infected women are at increased risk of developing cervical precancer
and cancer. [8–10]. Zambia has disproportionately high cervical cancer
incidence and mortality rates [4,11], as well as a generalized HIV/AIDS
epidemic [12].
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3. Preliminary activities
In 2005 the Zambian Ministry of Health facilitated the initiation of
the Cervical Cancer Prevention Program in Zambia (CCPPZ). Since in-
ception the CCPPZ has implemented nurse-led public cervical cancer
prevention service platforms where screening is performed by visual
inspection with acetic acid (VIA), followed by ablation with cryo-
therapy or thermal coagulation, excision with loop electrical excision
procedure (LEEP) or referral for biopsy [13]. To date CCPPZ has
screened over 500,000 women [14–16]. Supported by the U.S. Pre-
sident’s Emergency Plan for AIDS Relief (PEPFAR) through the Centers
for Disease Control and Prevention (CDC), as well as a prominent
public-private partnership − Pink Ribbon Red Ribbon − the CCPPZ
was able to build a highly efficient management and quality assurance
infrastructure. [14–16]
More recently, the Zambian government has accelerated its efforts
to expand breast cancer early detection and treatment capacity through
the initiation of a partner-sponsored effort with the Susan G. Komen
Breast Cancer Foundation. The model consists of breast cancer public
awareness campaigns, clinical breast examination (CBE) by nurses, ul-
trasound-guided biopsy of palpable breast masses by high-level
healthcare providers and referral for treatment. However, limited
funding and the lack of an efficient delivery and management system
preclude the availability of these services, except on a very small scale.
Despite these initiatives, there are no national-level data that map
women’s cancer control services in the country.
4. Methods
The overall aim of this project was to quantify existing service de-
livery capacity and to identify gaps, challenges, and priority areas of
focus for building setting-appropriate and sustainable breast and cer-
vical cancer control service platforms throughout Zambia.
The project provides an overview of services currently available for
breast and cervical cancer screening, early detection, diagnosis and
treatment in Zambia, obtained through a nationwide survey. The survey
was accomplished by conducting health facility assessments (HFAs) at
all 9 provincial hospitals in Zambia, as well as at the University
Teaching Hospital (UTH) and Cancer Diseases Hospital (CDH) in the
Lusaka Province. Provincial and tertiary facilities were the focus of the
assessment because they have been identified by the Zambian National
Cancer Control Strategic Plan as the highest priority facilities for ex-
pansion of cancer screening, early detection, and treatment services.
For each facility surveyed we assessed human resources (health care
providers with specialized training in breast and cervical cancer
screening, early detection and treatment) and facility infrastructure
(capacity, equipment, and supplies) to provide breast and cervical
cancer screening, early detection and treatment services, as well as HPV
vaccination services. Relevant referral systems were also assessed.
Concurrent with facility assessments, we conducted a structured inter-
view with each Provincial Health Officer, which included questions on
service provision, utilization, and costs to a patient for receiving breast
or cervical cancer screening, early detection, diagnosis, and treatment
in each district of the particular province. The availability of supplies
and equipment was also evaluated at the district level but was not
substantiated through visual inspection. All fieldwork was completed
between August 2014 and January 2015.
5. Results
5.1. Population
Zambia is divided into 10 provinces, comprised of 102 districts,
with a total population of 14,891,010. The target population for the
assessment was women aged 25–59 years (n = 2,208,870), who com-
prise ∼15% of Zambia’s population. Provincial Health Offices reported
1937 health facilities within the country, corresponding to a national
rate of 1.3 health facilities per 10,000. Although there are no estab-
lished benchmarks for the ideal number of health facilities, hospitals, or
hospital beds per 10,000 population, the World Health Organization
reports an average of 0.8 hospitals per 10,000 for the African region
[17].
5.2. Human resources
The paucity of human resources for health has previously been
noted as a limitation in patients’ access to breast and cervical cancer
care in Zambia. The Provincial Health Offices reported a total of 11,746
healthcare workers, including nurses (n = 9609), clinical officers
(n = 1179), general medical officers (n = 665), specialists (n = 104),
technologists (n = 109), and pharmacists or pharmacy technicians
(n = 80). Of these healthcare workers, 2955 (26%) are employed in the
provincial, tertiary, and specialty hospitals (2587 nurses, 249 general
medical officers, and 119 clinical officers). The provincial and tertiary
hospitals surveyed reported an additional 104 specialists (40 general
surgeons, 28 gynecologists, 6 clinical oncologists, 14 anesthesiologists,
7 radiologists, 9 pathologists), and 109 technologists (36 anesthetists,
42 radiographers, 27 histology technologists, and 4 cytology techni-
cians) (Fig. 1). The largest cadre of healthcare workers in the public
sector is nurses, who account for 82% of the total healthcare workers,
while specialists and technologists make up only 2%.
5.3. Service distribution
In most provinces, the provincial hospital is located in the pro-
vincial capital and also serves as the district hospital for that district. In
this analysis, all services provided at the provincial hospital are counted
toward services provided in that district.
Breast cancer screening (mammography), early detection (CBE) and
diagnostic (ultrasound, biopsy, pathology) services are not universally
available. Six out of 10 provinces have the potential capacity to offer
CBE and either mammography or ultrasound; neither Muchinga nor
Luapula Provinces report offering of any of these services. (Fig. 2).
All provincial hospitals provide cervical cancer “screen and treat”
services or refer to a nearby clinic; as a result, all provinces have at least
one district providing cervical cancer prevention. All provinces also
have at least one district outside the capital that provides cervical
cancer prevention services, with the exception of Muchinga Province.
Fig. 5 shows the provinces providing cervical cancer prevention in at
least one facility.
5.4. Breast cancer services
With respect to early detection and screening services, healthcare
workers trained to perform either CBE, ultrasound or mammography
are present in 8 of 11 hospitals. Two of the hospitals surveyed do not
have the capacity for CBE, ultrasound, or mammography (Fig. 2).
Three hospitals have dedicated breast specialty clinics, each of
which offers CBE, mammography, ultrasound and ultrasound-guided
breast biopsy (fine needle aspiration and core needle biopsy). These
clinics operate in Kabwe General Hospital (Central Province) one day
per week, University Teaching Hospital (Lusaka Province) every
weekday, and Cancer Diseases Hospital (Lusaka Province) three days
per week. Only 5 of the 11 hospitals were able to report numbers of
women assessed for breast cancer in the 12-month period preceding the
survey. The total number reported was 1414; of these, 839 (∼60%)
were screened at the Cancer Diseases Hospital in Lusaka.
The most common forms of breast cancer evaluation and treatment
are incisional or excisional wedge biopsy and mastectomy, both of
which are performed at 8 hospitals. One hospital charges for these
services. Radiation therapy is offered only at the Cancer Diseases
Hospital. Chemotherapy is offered at 4 hospitals, but mainly provided
at the Cancer Diseases Hospital. Endocrine (hormonal) therapy is of-
fered only at the Cancer Diseases Hospital.
Only a small proportion of the frontline healthcare workforce has
been trained to provide breast cancer specialty services. Of 2587 nurses
and midwives in the hospitals surveyed, 628 (24%) are trained in CBE,
but only 137 (5%) provide it. Of 249 General Medical Officers, 104
(42%) are trained in CBE and 91 (37%) provide it. The majority of
gynecologists are trained in (26; 93%) and reportedly provide CBE (27;
96%). Among 40 general surgeons, 22 (55%) are trained in incisional or
excisional wedge biopsy and mastectomy.
In this assessment, 9 of the hospitals reported having at least 1
mammography machine (10 machines in total, with 6 hospitals with
analog machines, 2 with digital machines, and 1 with both an analog
and a digital machine). Of the 9 hospitals with mammography ma-
chines, 7 machines were functional. All facilities reported at least one
functioning ultrasound machine (Fig. 3). However, we did not verify
the functional status of mammography and ultrasound machines, nor
whether ultrasound machines were equipped with the special probes
required for scanning the breasts.
There were no major gaps reported in availability of surgical
equipment or supplies for surgery or incisional/excisional breast
biopsy. All surgical facilities reported available and functional an-
esthesia and IV equipment, laryngoscopes, oropharyngeal airways, en-
dotracheal tubes, oxygen cylinders, operating tables, anesthetic face-
masks, and suction aspirators. All facilities also reported IV solution,
scalpels, sutures, and disinfectant currently in stock. CDH reported
having radiotherapy equipment. Once again, we did not verify the
functional status, quality, or quantity of supplies or equipment.
5.5. Cervical cancer services
All 11facilities provide cervical cancer screening, diagnosis, or
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Fig. 2. Breast Cancer Screening, Diagnosis, and
Treatment Services at 11 Provincial, Tertiary, and
Specialty Hospitals.
treatment of cancer precursors. In the 12-month period preceding the
survey, 27,369 women were screened for cervical cancer across the
11facilities surveyed. An additional 18,432 women were screened at
CCPPZ-supported facilities not included in this survey (45,801 in total).
While Kabwe General Hospital in the Central Province does not provide
cervical cancer screening, it refers patients to a nearby primary health
center (Ngungu Clinic), which has an active “screen and treat” pro-
gram. Two facilities offer cytology-based cervical cancer screening.
Nine facilities offer VIA, which is free of charge to patients in all and is
conducted by nurses and midwives. None currently offer HPV-based
screening. Cervical punch biopsy is offered in 10facilities. For cervical
cancer precursors, there are three types of treatment available: 9 of the
facilities surveyed provide cryotherapy, 10 provide loop electrical ex-
cision procedure (LEEP), and 1 offers cold-knife cervical conization. For
cases of early invasive cervical cancer, simple hysterectomy is available
at 8facilities and radical hysterectomy with pelvic lymphadenectomy is
available at UTH. As with breast cancer treatment, radiation is available
only at CDH. Chemotherapy for cervical cancer treatment is offered at
UTH, CDH, and Livingstone General Hospital, but primarily adminis-
tered at CDH. Brachytherapy is available only at CDH. Chemoradiation
and brachytherapy services are offered free of charge to patients
(Fig. 4).
HPV vaccination is not currently offered at any of these hospitals,
but was available in four districts in Lusaka Province through an ex-
ternally funded demonstration project.
Cervical cancer prevention and treatment capacity is distributed
among the healthcare workforce in the following manner. Among the
2587 nurses and midwives, 11 ( < 1%) are trained to perform Pap
smears and 31 (1%) VIA, 27 (1%) cryotherapy, and 10 ( < 1%) LEEP.
Only 4 ( < 1%) nurses are trained in HPV testing. Of 249 General
Medical Officers, 20 (8%) are trained to perform Pap smears and 18
(7%) VIA, 15 (6%) cryotherapy, 28 (11%) LEEP, and 45 (18%) cervical
punch biopsies. Almost all of the gynecologists are trained to perform
Pap smears and cold-knife conization, 21 (75%) VIA, and 20 (71%)
cryotherapy and LEEP. Of 40 general surgeons, 22 (55%) are trained in
simple hysterectomy. In some facilities, hysterectomies are conducted
by visiting gynecologists or expatriate gynecological surgeons, who are
not counted in the number of staff at that facility. Overall, only 33 (1%)
nurses and midwives and 17 (7%) GMOs are involved in the provision
of cervical cancer prevention services, while 25 (89%) gynecologists are
involved in such.
In this assessment, 9 of the hospitals reported having at least 1
cryotherapy machine and 10 reported having at least 1 LEEP machine.
Eight hospitals had at least one functioning digital camera for VIA. (One
additional hospital had a non-functioning camera.) Nine hospitals had
lithotomy beds, and all hospitals reported having at least 1 speculum.
All facilities that perform VIA screening reported having 5% acetic acid
for VIA in stock (Fig. 5).
5.6. Pathology services
Three hospitals reported having pathology labs at their facility:
UTH, Ndola Central Hospital, and Kabwe General Hospital. Patients pay
for pathology services at these facilities. Hospitals without pathology
labs send their specimens to private facilities (n = 6) and/or UTH
(n = 7). Two hospitals usually receive results within 1–2 weeks, 6 re-
ceive results within 3 or more weeks, and 3 were unable to estimate
how long it usually takes to receive results. In the 12-month period
preceding the survey, the UTH Pathology Lab processed 1800 speci-
mens, Ndola Central Hospital Pathology Lab processed 2325 specimens,
and the Kabwe General Hospital Pathology Lab processed 660 speci-
mens. Key pathology supplies such as 10% buffered formalin, H & E and
Geimsa stain solutions, pipettes, and microtome blades were available.
All three facilities’ centrifuges, microtomes, and tissue processors were
reported as functional.
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Fig. 4. Cervical Cancer Screening, Diagnosis, and
Treatment Services at 11 Provincial, Tertiary, and
Specialty Hospitals.
5.7. Summary of findings and recommendations
This report highlights the important cervical cancer prevention
gains that have been made in Zambia since the establishment of the
CCPPZ in 2005. Notably, cervical cancer screening services are pro-
vided in all 10 provinces of Zambia, with over 45,000 Zambian women
receiving screening services in the 12-month period preceding our
survey. By contrast, breast cancer screening and early detection services
are available in 8 of Zambia’s 10 provinces, but only 1414 women ac-
cessed them in the year preceding the survey. These numbers include
women attending both fixed and mobile clinics.
Several challenges common to both cervical and breast cancer ser-
vices emerged: (i) utilization of screening and early detection services
remains low, particularly for breast cancer; (ii) the capacity of pro-
vincial- and tertiary-level facilities to further expand and improve the
quality of women’s cancer services is severely curtailed by a lack of
appropriately trained mid- and high-level health personnel, limited
funding and pathology services; (iii) existing breast cancer screening
and early detection services are not well coordinated; and (iv) advanced
therapies (chemotherapy, radiation and oncologic surgery) are con-
centrated within the Lusaka Province.
Based on the above findings, the survey team provided the following
recommendations, many of which have since been implemented, at
least partially:
l. Administrative
(1)Establishing an Office of Women’s Cancer Control Services −
responsible for the expansion and coordination of all aspects of wo-
men’s cancer screening, early detection and diagnostic services in the
nation. The office should be supported by the following:
a. National Coordinator − responsible for overall leadership, plan-
ning, and administration of the activities of the office
b. Clinical Coordinator − responsible for the coordination and
management of all training and clinical activities
c. Provincial Women’s Cancer Control Specialists (one per province) −
responsible for the coordination, implementation, monitoring and
evaluation of women’s cancer services at the provincial level
These recommendations were accepted, further refined, and im-
plemented by the Zambian Ministry of Health. A new Office of National
Cancer Prevention, headquartered at the Ministry of Health, was in-
augurated in 2015 and Dr. Sharon Kapambwe, former staff head of
CCPPZ, was selected to be the National Cancer Prevention Coordinator.
In parallel, the reorganization of UTH has resulted in a separate hospital
specifically focused on women’s clinical care, directed by the founding
co-Director of CCPPZ, Dr. Mulindi Mwanahamuntu. In addition, Dr.
Aaron Shibemba, consultant pathologist for CCPPZ, was selected to be
the National Coordinator of Pathology and Laboratory services, a new




(1) Create cadres of Women’s Cancer Control Trainer of Trainers
(TOT) in each province, who will disseminate the following skills to
district level health facilities
• Women’s cancer health promotion
• Ablative and excisional treatment for cervical precancer
• Clinical breast examination and diagnostic breast ultrasound
• Ultrasound-guided breast biopsy (core needle biopsy and fine needle
aspiration)
• Point of care touch preparation cytology of breast biopsy specimens
(2) Convene a Women’s Cancer Control Consultative Meeting to
determine (a) how best to transition the cervical cancer prevention
program from opportunistic to population-based, and (b) the most ap-
propriate model for breast cancer control. The government is presently
collaborating with investigators from the University of North Carolina
and Research Triangle International to develop models for population-
based cervical cancer screening. The Susan G. Komen Breast Cancer
Foundation, in partnership with the Ministry of Health, is sponsoring
the consultative meeting in 2017.
(3)Convene a Pathology Consultative Meeting to assess existing
pathology and laboratory capacity in the country and develop models
for expansion.
(4) Apply for GAVI-supported HPV vaccines. The Ministry of Health
has reconvened its efforts to apply for GAVI-supported country-wide
HPV vaccination.
Medium Term
Establish a Women’s Oncology Surgical Training Institute at UTH to
train surgical oncologists. In July 2015, the Department of Obstetrics
and Gynecology at UTH established a Gynecologic Oncology Unit to
improve the care of women with gynecologic malignancies. In 2017 the
Cancer Diseases Hospital employed a gynecologist and general surgeon,
both of whom will undergo specialized surgical oncology training at an
accredited cancer care institution in the southern hemisphere in 2017.
Long Term
(1) Expand the graduate pathology training program. The residency
program in Pathology at UTH was established in 2011 and the first
group of 4 pathology residents completed their training in February
2017. Program expansion efforts are underway.
(2) Expand and strengthen the present national cancer registry to
monitor trends in cancer incidence, as well as project future funding
and service delivery needs
The Zambian Ministry of Health, as well as stakeholders from the
academic, non-profit, and industry sectors, have expressed strong
commitments in implementing these recommendations in the short
through long-term time horizons. The rapid translation of some of these
recommendations as discussed above demonstrate the willpower that
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